ILDSTAD SUZANNE (Chief Scientific Officer) sold 0.2% of their position (6.55K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/21/2023ACC: 0001209191-23-011019
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-6.55K
Net shares
Net seller
$13.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
6.55K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.94K
Price / share
$2.06
Trade value
$6.04K
% of position
0.1%
2/16/2023
3.08M→3.08M
Common Stock
Direct
Shares
−3.61K
Price / share
$2.05
Trade value
$7.41K
% of position
0.1%
2/17/2023
3.08M→3.07M
Total
Net shares
−6.55K
Net value
-$13.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2023 | S · Sale | −2.94K | $2.06 | $6.04K | 0.1% | 3.08M | 3.08M |
| Common Stock Direct | 2/17/2023 | S · Sale | −3.61K | $2.05 | $7.41K | 0.1% | 3.08M | 3.07M |
| Total | −6.55K | -$13.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned654.21K
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported